Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease

NCT00975195 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2488

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: tiotropium inhalation
DRUG: salmeterol xinafoate
DRUG: fluticasone propionate
DRUG: placebo matched for fluticasone propionate

Sponsor

Boehringer Ingelheim